Risk/Prevention: Module

CE / CME

Multidisciplinary Approaches for Evaluating Risk Factors and Preventive Measures for Transgender Individuals

Pharmacists: 0.50 contact hour (0.05 CEUs)

Physicians: Maximum of 0.50 AMA PRA Category 1 Credit

Nurses: 0.50 Nursing contact hour

Released: August 22, 2022

Expiration: August 21, 2023

Madeline B. Deutsch
Madeline B. Deutsch, MD, MPH

Activity

Progress
1
Course Completed
Referance

  1. James SE, Herman JL, Rankin S, et al. The report of the 2015 U.S. transgender survey. Washington, DC: National Center for Transgender Equality. 2016.
  2. Poteat T, Wirtz AL, Radix A, et al. HIV risk and preventive interventions in transgender women sex workers. Lancet. 2015;385:274-286.
  3. Association of American Medical Colleges. Culturally-sensitive care for transgender patients. www.aamc.org/about-us/equity-diversity-inclusion/lgbt-health-resources/culturally-sensitive-care. Accessed July 27, 2022.
  4. Centers for Disease Control and Prevention. Collecting sexual orientation and gender identity information. www.cdc.gov/hiv/clinicians/transforming-health/health-care-providers/collecting-sexual-orientation.html. Accessed July 27, 2022.
  5. Lekas H-M, Pahl K, Fuller Lewis C. Rethinking cultural competence: shifting to cultural humility. Health Serv Insights. 2020;13:117863292097058.
  6. Chan Swe N, Ahmed S, Eid M, et al. The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: a literature review. Metabol Open. 2022;13:100173.
  7. Martinez C, Rikhi R, Haque T, et al. Gender identity, hormone therapy, and vardiovascular fisease risk. Curr Probl Cardiol. 2020;45:100396.
  8. Heart Risk Calculator. www.cvriskcalculator.com/. Accessed July 27, 2022.
  9. Getahun D, Nash R, Flanders WD, et al. Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med. 2018;169:205-213.
  10. Alzahrani T, Nguyen T, Ryan A, et al. Cardiovascular disease risk factors and myocardial infarction in the transgender population. Circ Cardiovasc Qual Outcomes. Apr 2019;12:e005597.
  11. Sterling J, Garcia MM. Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model. Trans Androl Urol. 2020;9:2771-2785.
  12. Seay J, Ranck A, Weiss R, et al. Understanding transgender men's experiences with and preferences for cervical cancer screening: a rapid assessment survey. LGBT Health. 2017;4:304-309.
  13. Reisner SL, Deutsch MB, Peitzmeier SM, et al. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One. 2018;13:e0190172.
  14. Deutsch MB, Reisner SL, Peitzmeier S, et al. Recent penile sexual contact is associated with an increased odds of high-risk cervical human papillomavirus infection in transgender men. Sex Transm Dis. 2020;47:48-53.
  15. de Blok CJM, Wiepjes CM, Nota NM, et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ. 2019;365:l1652.
  16. Loverro G, Resta L, Dellino M, et al. Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals. Taiwan J Obstet Gynecol. 2016;55:686-691.
  17. Deutsch MB. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. Center for Excellence for Transgender Health. transcare.ucsf.edu/guidelines. Accessed July 27, 2022.
  18. Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319:1901-1913.
  19. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: prostate cancer early detection. v1.2022. www.nccn.org.
  20. de Blok CJ, Wiepjes CM, van Velzen DM, et al. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria. Lancet Diabetes Endocrinol. 2021;9:663-670.
  21. Cocchetti C, Romani A, Collet S, et al. The ENIGI (European Network for the Investigation of Gender Incongruence) study: overview of acquired endocrine knowledge and future perspectives. J Clin Med. 2022;11:1784.
  22. Streed CG Jr, Beach LB, Caceres BA, et al. Assessing and addressing cardiovascular health in people who are transgender and gender diverse: a scientific statement from the American Heart Association. Circulation. 2021;144:e136-e148.